Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Orwell who wrote (327)	1/11/2000 9:32:00 PM
From: Jon Koplik	Read Replies (1) \| Respond to of 805

Other than my usual "more buyers than sellers," I will actually attempt to say something useful (?) (after the following ...) (Right now, I have no position in CTII. I was long for quite a while. Bought some as high as $10 or $11,(also $8, $5, $4 ...) but -- due to massive purchases around $1, eventually "greased out" and got back all my money (plus "carrying charges") plus a little more when I got out last year at 1 11/16). Anyway -- I have always thought -- if we could just KNOW that CTII was NOT going to run out of money, I think the share price would easily be between $10 and $30. But, every time I looked into details on the company, I thought : "Boy, are these people still going to be in business in a year or two ?" I think what has happened in the past few days is : the big biotech stocks are now so incredibly "pricey," that it is no big deal to dare to buy CTII up to the $2 or $3 level, even though there is this problem that they are in a difficult financial position. Jon.